Search

Your search keyword '"Guo, Zifang"' showing total 168 results

Search Constraints

Start Over You searched for: Author "Guo, Zifang" Remove constraint Author: "Guo, Zifang" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
168 results on '"Guo, Zifang"'

Search Results

4. A unified framework for weighted parametric group sequential design (WPGSD)

8. γ-Radiolysis of the aqueous ammonia solution saturated by N2

12. Development Status and Prospect for the Medical Isotope Molybdenum-99 Produced by Electron Accelerator

13. Recent Advances in Nickel Catalysts with Industrial Exploitability for Copolymerization of Ethylene with Polar Monomers.

14. Radiolysis of aqueous solution containing copper ions

15. γ-radiolysis of boric acid-lithium hydroxide-ammonia coolant

16. Health-Related Quality of Life With Pembrolizumab+Chemotherapy Versus Placebo+Chemotherapy for Advanced Triple-Negative Breast Cancer: KEYNOTE-355

18. Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355.

20. Antiviral Activity, Safety, and Tolerability of Multiple Ascending Doses of Elbasvir or Grazoprevir in Participants Infected With Hepatitis C Virus Genotype-1 or -3

28. Production of 99Mo via photoneutron reaction using a 50 MeV electron linear accelerator.

31. Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer

33. Adsorption of aluminum via surface modification: An effective way to reduce the aluminum contamination presented in H2O2 plasma sterilization.

36. Abstract GS1-02: Final results of KEYNOTE-355: Randomized, double-blind, phase 3 study of pembrolizumab + chemotherapy vs placebo + chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer

38. One-step synthesis of hollow spherical polyethylene by dispersion polymerization

40. Physical mechanism of aluminum contamination presented in H2O2 plasma sterilization.

42. Abstract GS3-01: Additional efficacy endpoints from the phase 3 KEYNOTE-355 study of pembrolizumab plus chemotherapy vs placebo plus chemotherapy as first-line therapy for locally recurrent inoperable or metastatic triple-negative breast cancer

44. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

45. A directional circularly polarized crossed-dipole antenna with bandwidth enhancement

46. No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy

47. KEYNOTE-355: Randomized, double-blind, phase III study of pembrolizumab + chemotherapy versus placebo + chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer.

48. Assessment of Drug Interaction Potential Between the Hepatitis C Virus Direct‐Acting Antiviral Agents Elbasvir/Grazoprevir and the Nucleotide Analog Reverse‐Transcriptase Inhibitor Tenofovir Disoproxil Fumarate

49. Pharmacokinetic Interactions Between the Fixed‐Dose Combinations of Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine and Elbasvir/Grazoprevir in Healthy Adult Participants

Catalog

Books, media, physical & digital resources